Targeting Cancer Stem Cell Plasticity Through Modulation of Epidermal Growth Factor and Insulin‐Like Growth Factor Receptor Signaling in Head and Neck Squamous Cell Cancer

An in vitro system that recapitulates stem cell plasticity in head and neck squamous cell cancers (HNSCCs) was established and the factors that play a role in the maintenance and repopulation of cancer stem cells (CSCs) were identified. The results show that HNSCC CSCs exhibit plasticity, with maint...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stem cells translational medicine 2014-09, Vol.3 (9), p.1055-1065
Hauptverfasser: Leong, Hui Sun, Chong, Fui Teen, Sew, Pui Hoon, Lau, Dawn P., Wong, Bernice H., Teh, Bin-Tean, Tan, Daniel S.W., Iyer, N. Gopalakrishna
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:An in vitro system that recapitulates stem cell plasticity in head and neck squamous cell cancers (HNSCCs) was established and the factors that play a role in the maintenance and repopulation of cancer stem cells (CSCs) were identified. The results show that HNSCC CSCs exhibit plasticity, with maintenance of the stem cell fraction dependent on the epidermal growth factor receptor and insulin‐like growth factor‐1 receptor pathways and potentially amenable to targeted therapeutics. Emerging data suggest that cancer stem cells (CSCs) exist in equilibrium with differentiated cells and that stochastic transitions between these states can account for tumor heterogeneity and drug resistance. The aim of this study was to establish an in vitro system that recapitulates stem cell plasticity in head and neck squamous cell cancers (HNSCCs) and identify the factors that play a role in the maintenance and repopulation of CSCs. Tumor spheres were established using patient‐derived cell lines via anchorage‐independent cell culture techniques. These tumor spheres were found to have higher aldehyde dehydrogenase (ALD) cell fractions and increased expression of Kruppel‐like factor 4, SRY (sex determining region Y)‐box 2, and Nanog and were resistant to γ‐radiation, 5‐fluorouracil, cisplatin, and etoposide treatment compared with monolayer culture cells. Monolayer cultures were subject to single cell cloning to generate clones with high and low ALD fractions. ALDHigh clones showed higher expression of stem cell and epithelial‐mesenchymal transition markers compared with ALDLow clones. ALD fractions, representing stem cell fractions, fluctuated with serial passaging, equilibrating at a level specific to each cell line, and could be augmented by the addition of epidermal growth factor (EGF) and/or insulin. ALDHigh clones showed increased EGF receptor (EGFR) and insulin‐like growth factor‐1 receptor (IGF‐1R) phosphorylation, with increased activation of downstream pathways compared with ALDLow clones. Importantly, blocking these pathways using specific inhibitors against EGFR and IGF‐1R reduced stem cell fractions drastically. Taken together, these results show that HNSCC CSCs exhibit plasticity, with the maintenance of the stem cell fraction dependent on the EGFR and IGF‐1R pathways and potentially amenable to targeted therapeutics.
ISSN:2157-6564
2157-6580
DOI:10.5966/sctm.2013-0214